LAMPROGEN INC

Seattle, WA · Medtech · Private

Highly multiplexed PCR assay technology enabling detection of tens to hundreds of genetic targets in a single reaction

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Seattle, WA
Total capital
$10.9M
Federal grants
$10.9M
22 awards · 2016–2026
Rank in peer group#66 of 112
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
6 pending · first 2023
Rank in peer group#18 of 112

Capital timeline

201620182020202220242026FEDERAL ↑EQUITY ↓Cumulative $10.9M$981K$1.1M$530K$500K$851K$851K
201620182020202220242026FEDERAL ↑EQUITY ↓Cumulative $10.9M$981K$1.1M$851K$851K

Latest events

  • Federal grantHealth and Human S · Phase II · Deep Immunophenotyping in tissue imaging$851K
  • Federal grantHealth and Human S · Phase II · Deep Immunophenotyping in tissue imaging$851K
  • Federal grantHealth and Human S · Phase II · An expanded 75-color panel of Pdots for spectral multiplexing$500K
  • Federal grantHealth and Human S · Phase II · Significant expansion of spectral multiplexing in PCR$500K
  • Federal grantHealth and Human S · Phase II · An expanded 75-color panel of Pdots for spectral multiplexing$500K
  • Federal grantHealth and Human S · Phase II · An expanded 75-color panel of Pdots for spectral multiplexing$500K
  • Federal grantHealth and Human S · Phase II · Significant expansion of spectral multiplexing in PCR$500K
Show 15 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Significant expansion of spectral multiplexing in PCR$500K
  • Federal grantHealth and Human S · Phase I · Pdot Enabled Cyclic Imaging Cytometry$150K
  • Federal grantHealth and Human S · Phase I · Pdot Enabled Cyclic Imaging Cytometry$150K
  • Federal grantHealth and Human S · Phase II · Pdot-Enabled Point-of-Care Digital PCR for Sensitive Detection of SARS-CoV-2$410K
  • Federal grantHealth and Human S · Phase II · Ultra-Bright Fluorescent Probes for Flow Cytometry$495K
  • Federal grantHealth and Human S · Phase II · Self-Digitization Microfluidic Platform for Digital PCR$146K
  • Federal grantHealth and Human S · Phase II · Ultra-Bright Fluorescent Probes for Flow Cytometry$495K
  • Federal grantHealth and Human S · Phase II · Self-Digitization Microfluidic Platform for Digital PCR$530K
  • Federal grantHealth and Human S · Phase I · Ultra Bright Fluorescent Probes for Flow Cytometry$150K
  • Federal grantHealth and Human S · Phase I · Ultra-Bright Fluorescent Probes for Flow Cytometry$150K
  • Federal grantHealth and Human S · Phase II · Semiconducting Polymer Dots for Multiplexed Assays$490K
  • Federal grantHealth and Human S · Phase II · Self-Digitization Microfluidic Platform for Digital PCR$1.1M
  • Federal grantHealth and Human S · Phase II · Self-Digitization Microfluidic Platform for Digital PCR$469K
  • Federal grantHealth and Human S · Phase II · Semiconducting Polymer Dots for Multiplexed Assays$981K
  • Federal grantHealth and Human S · Phase II · Semiconducting Polymer Dots for Multiplexed Assays$490K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 112 peers

Line = median

Medtech · Instrument

  • Federal grantsBelow median
  • Granted patents#18 · top 16%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 9
Show all 9 patent records
  • Digital Amplification For Protein DetectionJan 15, 2026 · Application 19337738Pending
  • Digital Amplification For Protein DetectionJan 13, 2026 · US 12,523,651Granted
  • Nanoparticle Transducer Sensors And Methods Of Use ThereofApr 8, 2025 · US 12,270,067Granted
  • Transducers, Nanoparticle Transducer Devices And Systems, And Related Methods Of UseMay 25, 2023 · Application 17904916Pending
  • Nanoparticle Transducer Sensors And Methods Of Use ThereofJan 3, 2023 · US 11,542,539Granted
  • Nanoparticle Transducer Sensors And Methods Of Use ThereofApplication PCTUS2017035983Pending
  • Digital Amplification For Protein DetectionApplication PCTUS2019053034Pending
  • Transducers, Nanoparticle Transducer Devices And Systems, And Related Methods Of UseApplication PCTUS2021027454Pending
  • Isothermal Digital Amplification For Protein DetectionApplication 62736972Pending
  • BIOTISSUE HOLDINGS INC.Similar federal contract value in Medtech · null in contracts
  • CT RESOURCES INCSimilar federal contract value in Medtech · null in contracts
  • Avertix Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • Opus KSD, Inc.Similar federal contract value in Medtech · null in contracts
  • EPIFOCUS LLCSimilar federal contract value in Medtech · null in contracts
  • KINTARA THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .